Cell Lysis/Cell Fractionation Market by Product (Consumables, Instruments), Cell Type (Mammalian Cells, Microbial Cells), Application, End-User - Global Forecast 2024-2030

Cell Lysis/Cell Fractionation Market by Product (Consumables, Instruments), Cell Type (Mammalian Cells, Microbial Cells), Application, End-User - Global Forecast 2024-2030


The Cell Lysis/Cell Fractionation Market size was estimated at USD 3.35 billion in 2023 and expected to reach USD 3.63 billion in 2024, at a CAGR 8.55% to reach USD 5.95 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cell Lysis/Cell Fractionation Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cell Lysis/Cell Fractionation Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cell Lysis/Cell Fractionation Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Agilent Technologies, Inc., Beckman Coulter, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., Claremont BioSolutions, LLC, Covaris, LLC, Creative Biostructure, F. Hoffmann-La Roche Ltd., Geno Technology Inc., Invent Biotechnologies, Inc., Merck KGaA, Microfluidics International Corporation by IDEX Corporation, Miltenyi Biotec B.V. & Co. KG, Norgen Biotek Corp., NZYTech, Lda., Parr Instrument Company, Promega Corporation, PromoCell GmbH, Qiagen NV, Qsonica L.L.C, STEMCELL Technologies Inc., Takara Bio Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage


This research report categorizes the Cell Lysis/Cell Fractionation Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
Consumables
Beads

Disposables

Reagents & Kits
Instruments
Homogenizers

Sonicators
Cell Type
Mammalian Cells
Microbial Cells
Application
Nucleic Acid Purification & Isolation
Protein Purification & Isolation
End-User
Biopharmaceutical & Biotechnology Companies
Research Laboratories & Institutes
Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas
Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam
Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Cell Lysis/Cell Fractionation Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cell Lysis/Cell Fractionation Market?
3. What are the technology trends and regulatory frameworks in the Cell Lysis/Cell Fractionation Market?
4. What is the market share of the leading vendors in the Cell Lysis/Cell Fractionation Market?
5. Which modes and strategic moves are suitable for entering the Cell Lysis/Cell Fractionation Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Cell Lysis/Cell Fractionation Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Expanding healthcare, life sciences, and pharmaceutical industries
5.1.1.2. Increasing government funding for research in life sciences
5.1.1.3. Growing prevalence of diseases such as HIV/AIDS and cancer
5.1.2. Restraints
5.1.2.1. High cost of cell-based equipment and research
5.1.3. Opportunities
5.1.3.1. Growing focus on personalized medicine and the expansion of biopharmaceutical and biotechnology industries
5.1.3.2. Robust cell lysis/cell fractionation research activities across medical institutes
5.1.4. Challenges
5.1.4.1. Shortage of trained personnel for cell lysis/cell fractionation
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Cell Lysis/Cell Fractionation Market, by Product
6.1. Introduction
6.2. Consumables
6.3.1. Beads
6.3.2. Disposables
6.3.3. Reagents & Kits
6.3. Instruments
6.4.1. Homogenizers
6.4.2. Sonicators
7. Cell Lysis/Cell Fractionation Market, by Cell Type
7.1. Introduction
7.2. Mammalian Cells
7.3. Microbial Cells
8. Cell Lysis/Cell Fractionation Market, by Application
8.1. Introduction
8.2. Nucleic Acid Purification & Isolation
8.3. Protein Purification & Isolation
9. Cell Lysis/Cell Fractionation Market, by End-User
9.1. Introduction
9.2. Biopharmaceutical & Biotechnology Companies
9.3. Research Laboratories & Institutes
10. Americas Cell Lysis/Cell Fractionation Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Cell Lysis/Cell Fractionation Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Cell Lysis/Cell Fractionation Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Abcam PLC
14.1.2. Agilent Technologies, Inc.
14.1.3. Beckman Coulter, Inc.
14.1.4. Becton, Dickinson and Company
14.1.5. Bio-Rad Laboratories, Inc.
14.1.6. Cell Signaling Technology, Inc.
14.1.7. Claremont BioSolutions, LLC
14.1.8. Covaris, LLC
14.1.9. Creative Biostructure
14.1.10. F. Hoffmann-La Roche Ltd.
14.1.11. Geno Technology Inc.
14.1.12. Invent Biotechnologies, Inc.
14.1.13. Merck KGaA
14.1.14. Microfluidics International Corporation by IDEX Corporation
14.1.15. Miltenyi Biotec B.V. & Co. KG
14.1.16. Norgen Biotek Corp.
14.1.17. NZYTech, Lda.
14.1.18. Parr Instrument Company
14.1.19. Promega Corporation
14.1.20. PromoCell GmbH
14.1.21. Qiagen NV
14.1.22. Qsonica L.L.C
14.1.23. STEMCELL Technologies Inc.
14.1.24. Takara Bio Inc.
14.1.25. Thermo Fisher Scientific Inc.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
FIGURE 1. CELL LYSIS/CELL FRACTIONATION MARKET RESEARCH PROCESS
FIGURE 2. CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2023 VS 2030
FIGURE 3. CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CELL LYSIS/CELL FRACTIONATION MARKET DYNAMICS
FIGURE 7. CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2023 VS 2030 (%)
FIGURE 10. CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. CELL LYSIS/CELL FRACTIONATION MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. CELL LYSIS/CELL FRACTIONATION MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings